Merck & Co., Inc. (MRK)
Total Valuation
Merck & Co. has a market cap or net worth of $205.56 billion. The enterprise value is $221.99 billion.
| Market Cap | 205.56B |
| Enterprise Value | 221.99B |
Important Dates
The latest earnings date was Thursday, October 28, 2021 before market open.
| Last Earnings Date | Oct 28, 2021 |
| Ex-Dividend Date | Dec 14, 2021 |
Share Statistics
Merck & Co. has 2.53 billion shares outstanding. The number of shares has increased by 0.08% in one year.
| Shares Outstanding | 2.53B |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 74.54% |
| Float | 2.52B |
Valuation Ratios
The trailing PE ratio is 28.72 and the forward PE ratio is 10.10. Merck & Co.'s PEG ratio is 1.16.
| PE Ratio | 28.72 |
| Forward PE | 10.10 |
| PS Ratio | 4.18 |
| PB Ratio | 5.74 |
| P/FCF Ratio | 24.68 |
| PEG Ratio | 1.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.42, with a EV/FCF ratio of 26.65.
| EV / Earnings | 30.84 |
| EV / Sales | 4.52 |
| EV / EBITDA | 18.42 |
| EV / EBIT | 25.31 |
| EV / FCF | 26.65 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.74.
| Current Ratio | 1.31 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 2.19 |
| Debt / FCF | 3.17 |
Financial Efficiency
Return on equity (ROE) is 23.70%, which is very high. The company has a high ROIC of 16.10%.
| Return on Equity (ROE) | 23.70% |
| Return on Assets (ROA) | 7.90% |
| Return on Capital (ROIC) | 16.10% |
| Revenue Per Employee | $673,301 |
| Profits Per Employee | $98,589 |
| Employee Count | 73,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.69 |
Taxes
In the past 12 months, Merck & Co. has paid $1.57 billion in taxes.
| Income Tax | 1.57B |
| Effective Tax Rate | 17.93% |
Stock Price Statistics
The stock price has decreased by -2.60% in the last 52 weeks. The beta is 0.50, so Merck & Co.'s price volatility has been lower than the market average.
| Beta (1Y) | 0.50 |
| 52-Week Price Change | -2.60% |
| 50-Day Moving Average | 76.18 |
| 200-Day Moving Average | 77.14 |
| Average Volume (30 Days) | 13,782,400 |
Short Selling Information
| Short Interest | 23.16M |
| Short % of Shares Out | 0.92% |
| Short % of Float | 0.92% |
| Short Ratio (days to cover) | 1.66 |
Income Statement
In the last 12 months, Merck & Co. had revenue of $49.15 billion and earned 7.20 billion in profits. Earnings per share was $2.83.
| Revenue | 49.15B |
| Gross Profit | 33.39B |
| Operating Income | 7.20B |
| Pretax Income | 8.77B |
| Net Income | 7.20B |
| EBITDA | 12.05B |
| EBIT | 8.77B |
| Earnings Per Share (EPS) | $2.83 |
Balance Sheet
The company has $10.02 billion in cash and $26.44 billion in debt, giving a net cash position of -$16.43 billion or -$6.50 per share.
| Cash & Cash Equivalents | 10.02B |
| Total Debt | 26.44B |
| Net Cash | -16.43B |
| Net Cash Per Share | -$6.50 |
| Book Value | 35.79B |
| Book Value Per Share | 14.17 |
| Working Capital | 7.33B |
Cash Flow
In the last 12 months, operating cash flow was $13.08 billion and capital expenditures -$4.75 billion, giving a free cash flow of $8.33 billion.
| Operating Cash Flow | 13.08B |
| Capital Expenditures | -4.75B |
| Free Cash Flow | 8.33B |
| FCF Per Share | $3.30 |
Margins
Gross margin is 67.94%, with operating and profit margins of 14.64% and 14.64%.
| Gross Margin | 67.94% |
| Operating Margin | 14.64% |
| Pretax Margin | 17.84% |
| Profit Margin | 14.64% |
| EBITDA Margin | 24.52% |
| EBIT Margin | 17.84% |
| FCF Margin | 16.95% |
Dividends & Yields
This stock pays an annual dividend of $2.61, which amounts to a dividend yield of 3.21%.
| Dividend Per Share | $2.61 |
| Dividend Yield | 3.21% |
| Earnings Yield | 3.50% |
| FCF Yield | 4.05% |
| Dividend Growth (YoY) | 6.56% |
| Payout Ratio | 91.20% |
Stock Splits
The last stock split was on June 3, 2021. It was a forward split with a ratio of 1048:1000.
| Last Split Date | Jun 3, 2021 |
| Split Type | Forward |
| Split Ratio | 1048:1000 |